NanoPass Technologies Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:NanoPass Technologies Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011462
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and markets intradermal delivery solutions for vaccines and drugs. The company offers product such as MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its products are used with any standard syringe to inject drugs, proteins, and vaccines directly into the skin. NanoPass also develops hollow microneedles for solid microprojections and intradermal injections for cosmetic use. The company conducts clinical studies in North America, Europe, Israel, Hong Kong, Brazil, Bangladesh, and Japan. It supports multiple phase I-III clinical studies and partners with vaccine and immunotherapy product developers. NanoPass is headquartered in Nes Ziona, Israel.

NanoPass Technologies Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NanoPass Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NanoPass Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NanoPass Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NanoPass Technologies Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NanoPass Technologies Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
NanoPass Technologies Raises Funds Through Series B Financing 10
Partnerships 11
Circassia Pharma Enters into Licensing Agreement with NanoPass Technologies 11
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 12
NanoPass Technologies Enters Into Licensing Agreement With Circassia 13
IDRI and NanoPass Tech Enter into Development Agreement 14
Acquisition 15
West Pharma Invests in NanoPass Technologies 15
NanoPass Technologies Ltd – Key Competitors 16
NanoPass Technologies Ltd – Key Employees 17
NanoPass Technologies Ltd – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
NanoPass Technologies Ltd, Medical Equipment, Key Facts 2
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NanoPass Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
NanoPass Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
NanoPass Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
NanoPass Technologies Ltd, Deals By Market, 2011 to YTD 2017 8
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NanoPass Technologies Raises Funds Through Series B Financing 10
Circassia Pharma Enters into Licensing Agreement with NanoPass Technologies 11
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 12
NanoPass Technologies Enters Into Licensing Agreement With Circassia 13
IDRI and NanoPass Tech Enter into Development Agreement 14
West Pharma Invests in NanoPass Technologies 15
NanoPass Technologies Ltd, Key Competitors 16
NanoPass Technologies Ltd, Key Employees 17

★海外企業調査レポート[NanoPass Technologies Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avid Bioservices Inc (CDMO):製薬・医療:M&Aディール及び事業提携情報
    Summary Avid Bioservices Inc (Avid Bioservices), formerly Peregrine Pharmaceuticals Inc, is a biopharmaceutical company that develops, manufactures and markets monoclonal antibodies for the treatment and diagnosis of cancer. The company’s products include Bavituximab, PGN650 and Cotara. Its Bavituxi …
  • Dermira Inc (DERM):製薬・医療:M&Aディール及び事業提携情報
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Ferring International Center SA-医療機器分野:企業M&A・提携分析
    Summary Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (foll …
  • Toyota Tsusho Corporation:企業の戦略・SWOT・財務分析
    Toyota Tsusho Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Tsusho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Universal Electronics Inc (UEIC):企業の財務・戦略的SWOT分析
    Summary Universal Electronics Inc (Universal Electronics) is a technology company that offers control and sensor technology solutions. The company offers a range of pre-programmed and universal remote control products, audio-video accessories, intelligent wireless security and automation components, …
  • Taragenyx Ltd:企業の製品パイプライン分析2018
    Summary Taragenyx Ltd (Taragenyx) is a medical technology company that provides regenerative medicine technology, medical and biological engineering solutions. The company offers restorative implant solutions generation, burdensome operations, and medical, orthopaedic, dental implantation solutions, …
  • Korres Natural Products SA:戦略・SWOT・企業財務分析
    Korres Natural Products SA - Strategy, SWOT and Corporate Finance Report Summary Korres Natural Products SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ultrapar Participacoes SA (UGPA3):企業の財務・戦略的SWOT分析
    Ultrapar Participacoes SA (UGPA3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Reckitt Benckiser Group plc:企業のM&A・事業提携・投資動向
    Reckitt Benckiser Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reckitt Benckiser Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • City Holding Co (CHCO):企業の財務・戦略的SWOT分析
    City Holding Co (CHCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Case Western Reserve University-製薬・医療分野:企業M&A・提携分析
    Summary Case Western Reserve University (CWRU) is a private research university that offers educational and research programs. The institute provides bachelor, master’s, doctoral and research programs through its colleges and professional schools, besides postdoctoral training. It offers courses in …
  • Pakistan Oxygen Limited (LINDE):企業の財務・戦略的SWOT分析
    Pakistan Oxygen Limited (LINDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orsted AS (DENERG)-石油・ガス分野:企業M&A・提携分析
    Summary Orsted AS (Orsted) formerly Dong Energy A/S is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conventional fuel and wind energy sources. The company also develops, constructs, owns and o …
  • KineMed Inc-製薬・医療分野:企業M&A・提携分析
    Summary KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs …
  • CVR Energy, Inc.:企業の戦略・SWOT・財務分析
    CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Orchid Orthopedic Solutions LLC:医療機器:M&Aディール及び事業提携情報
    Summary Orchid Orthopedic Solutions LLC (Orchid Orthopedic) is a medical device manufacturing company that offers orthopedic and medical device contract design, and manufacturing outsourcing services. The company provides proprietary solutions such as implant bone in-growth coatings, medical device …
  • The Real Good Food Company plc:戦略・SWOT・企業財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • National Railroad Passenger Corporation:企業の戦略・SWOT・財務情報
    National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report Summary National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Steel Authority of India Ltd:企業のM&A・事業提携・投資動向
    Steel Authority of India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Steel Authority of India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆